2 months ago
MRK
AnalystsEmily FieldEmily Field's Stock Forecasts
AnalystsEmily Field
Sectors:
Industries:
Analyst Ranking
Bottom 27%
#3878 out of 5263 analysts
Average Return
-1.67%
Win Rate
17%1 out of 6
Risk vs Reward
Poor
Good
Emily Field's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +27.02% | $295.58 | $375.44 | 2021-10-18 - 2022-10-18 | Strong Buy |
Emily Field Analyst Color
Get additional color on Emily Field's coverage of popular stocks
2 months ago
LLY
Emily Field's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 1 | Strong Sell | $25.00 | -7.41% | Initiates Coverage On | 2 months ago |
Merck & Co IncMRK | 1 | Strong Buy | $140.00 | +25.11% | Initiates Coverage On | 2 months ago |
Gilead Sciences IncGILD | 1 | Hold | $155.00 | +18.87% | Initiates Coverage On | 2 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $1,350.00 | +52.72% | Initiates Coverage On | 2 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $75.00 | +27.75% | Initiates Coverage On | 2 months ago |
Biogen IncBIIB | 1 | Hold | $185.00 | +0.34% | Initiates Coverage On | 2 months ago |
Amgen IncAMGN | 1 | Hold | $350.00 | +1.58% | Initiates Coverage On | 2 months ago |
Abbvie IncABBV | 1 | Strong Buy | $275.00 | +38.39% | Initiates Coverage On | 2 months ago |
Argenx SeARGX | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.